がん免疫療法の世界市場:モノクローナル抗体、免疫チェックポイント阻害薬、がんワクチン...市場調査レポートについてご紹介

【英文タイトル】Global Cancer Immunotherapies Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Overview of cancer immunotherapies
• Epidemiology
• Spending on cancer
• Cost of cancer treatment
• Reimbursement policies
• Economic burden of cancer
• Orphan drug designation and regulatory approvals

PART 06: Pipeline portfolio
• Anticipated number of products with single and multi-indications by 2020

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by type
• Cancer monoclonal antibodies
• Clinical trials of cancer monoclonal antibodies
• Immune checkpoint inhibitors
• Cancer vaccines
• Non-specific immunotherapies
• Global cancer monoclonal antibodies market
• Global cancer vaccines market
• Global immune checkpoint inhibitors market
• Global non-specific immunotherapies market

PART 09: Geographical segmentation
• Global cancer immunotherapies market by geography 2015-2020
• Cancer immunotherapies market in Americas
• Cancer immunotherapies market in EMEA
• Cancer immunotherapies market in APAC

PART 10: Market drivers
• Increase in prevalence of cancers
• Increase in demand for cancer monoclonal antibodies
• Patient assistance programs
• Promising pipeline

PART 11: Impact of drivers

PART 12: Market challenges
• Patent expiry of top-selling drugs
• Poor diagnosis and screening
• High developmental costs
• Risk of side-effects
• Stringent regulations

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Increase in cancer awareness
• Emergence of targeted and combination therapies
• Emergence of biosimilars
• Strategic alliances

PART 15: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Amgen
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Merck
• Takeda Pharmaceuticals1
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Cancer immunotherapies in global cancer drugs market
Exhibit 03: Global incidence of cancer by type 2015
Exhibit 04: Global mortality by cancer type 2015
Exhibit 05: Estimated numbers of male and female cancer survivors by age in US 2014
Exhibit 06: Spending on cancer by distribution channels 2013
Exhibit 07: Annual treatment cost per patient for cancer immunotherapies 2014
Exhibit 08: Average cost of surgeries associated with cancer ($ millions) 2014
Exhibit 09: National reimbursement of cancer drugs by countries 2014
Exhibit 10: US FDA Orphan drug designations and approvals for cancer immunotherapies
Exhibit 11: EU orphan drug designations and approvals for cancer immunotherapies
Exhibit 12: Key events in cancer immunotherapies, discovery, and approvals
Exhibit 13: Timeline of some cancer immunotherapies
Exhibit 14: Phase III pipeline molecules for global cancer monoclonal antibodies market
Exhibit 15: Phase II pipeline molecules for global cancer monoclonal antibodies market
Exhibit 16: Phase I pipeline molecules for global cancer monoclonal antibodies market
Exhibit 17: Pipeline molecules for global immune checkpoint inhibitors market
Exhibit 18: Phase III pipeline molecules for global cancer vaccines market
Exhibit 19: Near-launch immuno-oncology pipeline assets
Exhibit 20: Global cancer immunotherapies market 2015-2020 ($ billions)
Exhibit 21: Factors influencing global cancer immunotherapies market
Exhibit 22: Five forces analysis
Exhibit 23: Global cancer immunotherapies market by type 2015
Exhibit 24: Timeline for approvals of cancer monoclonal antibodies by US FDA
Exhibit 25: Clinical trials of cancer monoclonal antibodies by development phase
Exhibit 26: Status of clinical trials of cancer monoclonal antibodies
Exhibit 27: Global cancer immunotherapies market by type of cancer immunotherapies 2015
Exhibit 28: Global cancer immunotherapies market by type of cancer immunotherapies 2015-2020 ($ billions)
Exhibit 29: Global cancer monoclonal antibodies market 2015-2020 ($ billions)
Exhibit 30: Key drivers and challenges of global cancer monoclonal antibodies market
Exhibit 31: Global cancer vaccines market 2015-2020 ($ billions)
Exhibit 32: Global cancer vaccines market by application 2015
Exhibit 33: Key drivers and challenges of global cancer vaccines market
Exhibit 34: Global immune checkpoint inhibitors market 2015-2020 ($ billions)
Exhibit 35: Key drivers and challenges for global immune checkpoint inhibitors market
Exhibit 36: Global non-specific immunotherapies market 2015-2020 ($ billions)
Exhibit 37: Global cancer immunotherapies market by geography 2015
Exhibit 38: Global cancer immunotherapies market revenue by geography 2015-2020 ($ billions)
Exhibit 39: Cancer immunotherapies market in Americas 2015-2020 ($ billions)
Exhibit 40: Cancer immunotherapies market in EMEA 2015-2020 ($ billions)
Exhibit 41: Cancer immunotherapies market in APAC 2015-2020 ($ billions)
Exhibit 42: Global incidence of cancer 2015 and 2020 in millions
Exhibit 43: Impact of drivers
Exhibit 44: Patent expiries of major cancer monoclonal antibodies by 2020
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Expected combination regimen launches in oncology
Exhibit 47: Top cancer immunotherapies based on sales 2014 ($ billions)
Exhibit 48: YoY Sales comparison of top drugs 2011-2014 ($ billions)
Exhibit 49: Cancer immunotherapy companies by origin country
Exhibit 50: Amgen: YoY growth and revenue generated from net product sales of Xgeva 2011-2014 ($ millions)
Exhibit 51: Amgen: YoY growth and revenue generated from net product sales of Prolia 2011-2014 ($ millions)
Exhibit 52: Amgen: YoY growth and revenue generated from net product sales of Vectibix worldwide excluding Japan 2011-2014 ($ millions)
Exhibit 53: Amgen: YoY growth and revenue of Vectibix in US 2012-2014 ($ millions)
Exhibit 54: Amgen: YoY growth and revenue of Vectibix in ROW 2012-2014 ($ millions)
Exhibit 55: Amgen: Key takeaways
Exhibit 56: Bristol-Myers Squibb: Segmentation by revenue 2014
Exhibit 57: Bristol-Myers Squibb: Revenue of oncology products by category 2014
Exhibit 58: Bristol-Myers Squibb: YoY growth and revenue generated from net product sales of Yervoy 2011-2014 ($ millions)
Exhibit 59: Bristol-Myers Squibb: YoY growth and revenue of Erbitux in US, Canada, and Japan 2010-2014 ($ millions)
Exhibit 60: Bristol-Myers Squibb: Key takeaways
Exhibit 61: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of MabThera/Rituxan 2011-2014 ($ billions)
Exhibit 62: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Avastin 2011-2014 ($ billions)
Exhibit 63: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Herceptin 2011-2014 ($ billions)
Exhibit 64: F. Hoffmann-La Roche: YoY growth and revenue of Herceptin in US 2013-2014 ($ billions)
Exhibit 65: F. Hoffmann-La Roche: YoY growth and revenue of Herceptin in EU 2013-2014 ($ billions)
Exhibit 66: F. Hoffmann-La Roche: YoY growth and revenue of Herceptin in Japan 2013-2014 ($ millions)
Exhibit 67: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Perjeta 2012-2014 ($ millions)
Exhibit 68: F. Hoffmann-La Roche: Revenue generated from net product sales of Kadcyla 2013-2014 ($ millions)
Exhibit 69: F. Hoffmann-La Roche: Key takeaways
Exhibit 70: GlaxoSmithKline: YOY growth and revenue of Arzerra 2012-2014 ($ millions)3
Exhibit 71: GlaxoSmithKline: YOY growth and revenue of Cervarix 2012-2014 ($ millions)3
Exhibit 72: GlaxoSmithKline: Key takeaways
Exhibit 73: Merck: YoY growth and revenue of Gardasil 2012-2014 ($ billions)6
Exhibit 74: Merck: YoY growth and revenue generated from net product sales of Erbitux, excluding US, Canada, and Japan 2011-2014 ($ billions
Exhibit 75: Merck: YOY growth and revenue of Erbitux in Europe 2012-2014 ($ millions)
Exhibit 76: Merck: YOY growth and revenue of Erbitux in emerging markets 2012-2014 ($ millions)
Exhibit 77: Merck: YOY growth and revenue of Erbitux in ROW 2012-2014 ($ millions)
Exhibit 78: Merck: Region-wise revenues of Erbitux 2012-2014 ($ millions)
Exhibit 79: Merck: Key takeaways
Exhibit 80: Takeda Pharmaceuticals: YoY growth and revenue generated from net product sales of Adcetris ($ millions)
Exhibit 81: Takeda Pharmaceuticals: YoY growth and revenue of Vectibix in Japan ($ millions)
Exhibit 82: Takeda Pharmaceuticals: Key takeaways


【レポート販売概要】

■ タイトル:がん免疫療法の世界市場:モノクローナル抗体、免疫チェックポイント阻害薬、がんワクチン
■ 英文:Global Cancer Immunotherapies Market 2016-2020
■ 発行日:2016年4月27日
■ 調査会社:Technavio
■ 商品コード:IRTNTR8400
■ 調査対象地域:グローバル
  • 脳動脈瘤(Cerebral Aneurysms):世界の治験レビュー(2015年上半期版)
    Cerebral Aneurysms Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H1, 2015" provides data on the Cerebral Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Aneurysms. It includes an overview of the trial numbers and their recruitme …
  • オレイン酸オレイルの世界市場2015
    Oleyl Oleate (CAS 3687-45-4) Market Research Report 2015 aims at providing comprehensive data on Oleyl Oleate market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Oleyl Oleate description, covers its application areas, manufacturing methods, patterns. It captures Oleyl Oleate market trends, pays close attention to Oleyl Oleate manufacturers and names …
  • 世界のスマートテレビ用高周波デバイス市場:アンテナ・スイッチ、復調器、パワーアンプ、RFフィルタ、チューナー
    About Smart TV RF Devices Smart TV, also known as connected TV or hybrid TV, is a TV with integrated internet capabilities or a TV set-top box that offers advanced connectivity and computing abilities. Smart TV allows users to install and run advanced applications based on specific platforms. RF devices use RF technology and are deployed in various wired and wireless communication devices such as …
  • M2Mの技術要因、マーケットダイナミクス及び産業(M2M Technology Drivers, Market Dynamics, and Industry Verticals)
    The M2M ecosystem has gained significant momentum recently, driven largely by necessity as cellular service provider revenue opportunities diminish due to flattening mobile subscriber base growth. Network operators have recognized the need to leverage their substantial investment in infrastructure to offer M2M as a value-added services that will add new sources of revenue. However, growth in M2M i …
  • 非破壊検査(NDT)装置及びサービスの世界市場:超音波探傷試験、電磁誘導試験、渦電流探傷試験、浸透探傷試験、放射線透過試験など
    Non-Destructive Testing (NDT) is the process of inspecting, testing, or evaluating materials, components, or assemblies for discontinuities or differences in characteristics without altering the original attributes. It has the property to determine the discontinuities and differences in material characteristics. Non-Destructive Testing (NDT) is broadly divided into NDT equipment and NDT services m …
  • Comstock Resources, Inc.社の石油・ガス開発・生産動向及びコスト分析(2013年第4四半期)
    Comstock Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Comstock Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
  • モバイル/マイクロ・データセンターのグローバル市場
    Evolutionary advancement in data center over the past several decades, from the mainframe era to client/server computing, and then on to the virtual data centre has changed the data center development and deployment to cater unique requirements of businesses and enterprises. Micro Datacenter solution providers handle internet and business generated data to maintain, monitor and reporting on consol …
  • コハク酸の世界市場予測(~2023年)
    “The succinic acid market is projected to register a CAGR of 6.8% between 2018 and 2023.”The global succinic acid market is estimated to be USD 132 million in 2018 and is projected to reach USD 183 million by 2023, at a CAGR of 6.8%. The increasing demand from the industrial, personal care and food & beverage industries fuels the succinic acid market. The increasing demand from the APAC region, an …
  • 掘削ドリルビットの世界市場:ロータリービット、DTHハンマービット
    The global mining drill bits market was valued at $1,145,000 thousand in 2018, and is projected to reach $1,711,800 thousand by 2026, growing at a CAGR of 5.1% from 2019 to 2026. Mining drill bits are cutting tools that are used to dig the hole of circular area. These drill bits are deployed to remove rock or debris material to create different size of holes. There are certain specialized mining d …
  • Brivaracetam (Epilepsy):市場予測と分析(~2022)
    Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Brivaracetam (Epilepsy) - Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction …
  • バイオスティミュラント(生物刺激剤)の世界市場予測(~2022年):フミン質、海藻、微生物、微量ミネラル、ビタミン、アミノ酸
    The biostimulants market is projected to grow at a CAGR of 10.43% from USD 2.00 Billion in 2017, to reach USD 3.29 Billion by 2022. Due to the implementation of sustainable agriculture, biostimulants have been gaining a preference for their ease of application, target-specificity, and less toxicity to both the environment and human health, thus limiting the use of harmful chemicals. On the basis o …
  • Respiratory Diseases in the UK 2014: Market Outlook and Emerging Opportunities
    About This ReportThis new 281-page report from Venture Planning Group presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.In additio …
  • 妊婦向けビタミンサプリメントの世界市場2016-2020
    About the Prenatal Vitamin Supplement Market A dietary supplement is a product that is intended for ingestion and contains dietary ingredients that add nutritional value. A dietary supplement is available in one or in combination of substances such as minerals, amino acids, vitamins, and herbs. It may be available in various forms such as powders, pills, tablets, liquids, and gel capsules. Dietary …
  • 太陽電池バックシートの世界市場2019-2023
    About this market Increased adoption of microgrids to drive market growth. Microgrids are small-scale power grids that have their own generation and storage resources. Microgrids can operate independently or collaboratively with other small power grids. A microgrid can connect and disconnect from the main power grid to operate in grid-connected mode and in island mode. Additionally, when integrate …
  • 世界における医薬品包装(パッケージ)企業の上位20社分析:事業分野、重点地域、戦略、将来展望
    Visiongain assesses that the healthcare packaging market is highly fragmented with the top 20 companies accounting for just 32% of the global healthcare packaging market in 2014. The healthcare packaging market still has vast potential. In a global, interconnected economy, where the ease and immediacy of social interactions make the world a smaller place, such trends are also having an impact on h …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。